The dominant market consensus around an 85–90 cumulative influenza-associated hospitalization rate for Week 21, 2026, reflects CDC FluSurv-NET surveillance data showing steady accumulation through the season's peak and shoulder weeks. Weekly rates have fallen sharply from highs above 12 per 100,000 in late December 2025 to just 0.2 per 100,000 by Week 18 in mid-May, pushing the cumulative total to 86.3 per 100,000 with only modest further gains expected amid low transmission. Official estimates place total season hospitalizations near 380,000, consistent with a moderately severe H3N2-dominated season that ranks among the higher cumulative burdens since 2010–2011. Minimal new admissions forecasted through early June support the narrow band, though final resolution remains subject to routine data revisions and any late-season reporting adjustments from the surveillance network.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertFlu Hospitalization Rate Week 21, 2026?
Flu Hospitalization Rate Week 21, 2026?
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$5,474 Vol.
$5,474 Vol.
5. Juni 2026
<80
No
80–85
No
85–90
Yes
90–95
No
95–100
No
100+
No
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$5,474 Vol.
$5,474 Vol.
5. Juni 2026
<80
$647 Vol.
No
80–85
$360 Vol.
No
85–90
$1,193 Vol.
Yes
90–95
$1,382 Vol.
No
95–100
$928 Vol.
No
100+
$964 Vol.
No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The dominant market consensus around an 85–90 cumulative influenza-associated hospitalization rate for Week 21, 2026, reflects CDC FluSurv-NET surveillance data showing steady accumulation through the season's peak and shoulder weeks. Weekly rates have fallen sharply from highs above 12 per 100,000 in late December 2025 to just 0.2 per 100,000 by Week 18 in mid-May, pushing the cumulative total to 86.3 per 100,000 with only modest further gains expected amid low transmission. Official estimates place total season hospitalizations near 380,000, consistent with a moderately severe H3N2-dominated season that ranks among the higher cumulative burdens since 2010–2011. Minimal new admissions forecasted through early June support the narrow band, though final resolution remains subject to routine data revisions and any late-season reporting adjustments from the surveillance network.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Markt eröffnet: Jun 1, 2026, 12:42 PM ET
Volumen
$5,474Enddatum
5. Juni 2026Markt eröffnet
Jun 1, 2026, 12:42 PM ETAbwicklungsquelle
https://www.cdc.gov/fluview/index.htmlResolver
0x69c47De9D...Vorgeschlagenes Ergebnis: No
Kein Einspruch
Endgültiges Ergebnis: No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The dominant market consensus around an 85–90 cumulative influenza-associated hospitalization rate for Week 21, 2026, reflects CDC FluSurv-NET surveillance data showing steady accumulation through the season's peak and shoulder weeks. Weekly rates have fallen sharply from highs above 12 per 100,000 in late December 2025 to just 0.2 per 100,000 by Week 18 in mid-May, pushing the cumulative total to 86.3 per 100,000 with only modest further gains expected amid low transmission. Official estimates place total season hospitalizations near 380,000, consistent with a moderately severe H3N2-dominated season that ranks among the higher cumulative burdens since 2010–2011. Minimal new admissions forecasted through early June support the narrow band, though final resolution remains subject to routine data revisions and any late-season reporting adjustments from the surveillance network.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$5,474Enddatum
5. Juni 2026Markt eröffnet
Jun 1, 2026, 12:42 PM ETAbwicklungsquelle
https://www.cdc.gov/fluview/index.htmlResolver
0x69c47De9D...Vorgeschlagenes Ergebnis: No
Kein Einspruch
Endgültiges Ergebnis: No
The dominant market consensus around an 85–90 cumulative influenza-associated hospitalization rate for Week 21, 2026, reflects CDC FluSurv-NET surveillance data showing steady accumulation through the season's peak and shoulder weeks. Weekly rates have fallen sharply from highs above 12 per 100,000 in late December 2025 to just 0.2 per 100,000 by Week 18 in mid-May, pushing the cumulative total to 86.3 per 100,000 with only modest further gains expected amid low transmission. Official estimates place total season hospitalizations near 380,000, consistent with a moderately severe H3N2-dominated season that ranks among the higher cumulative burdens since 2010–2011. Minimal new admissions forecasted through early June support the narrow band, though final resolution remains subject to routine data revisions and any late-season reporting adjustments from the surveillance network.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen